Adalimumab/tocilizumabLack of efficacy: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1967卷 / 1期

关键词：

D O I：

10.1007/s40278-023-43830-7

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：23 / 23

相关论文

共 50 条

[1] TocilizumabLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1938 (1) : 1191 - 1191
[2] TocilizumabLack of efficacy: 3 case reports
Reactions Weekly, 2023, 1972 (1) : 329 - 329
[3] TocilizumabLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1925 (1) : 474 - 474
[4] TocilizumabLack of efficacy: 10 case reports
Reactions Weekly, 2021, 1886 (1) : 371 - 371
[5] Methylprednisolone/tocilizumabLack of efficacy in off-label use: 7 case reports
Reactions Weekly, 2021, 1857 (1) : 206 - 206
[6] Infliximab/tocilizumabLack of efficacy: 2 case reports
Reactions Weekly, 2024, 2027 (1) : 238 - 238
[7] Allopurinol/steroids/tocilizumabLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1943 (1) : 35 - 35
[8] TocilizumabLack of efficacy and off label use: 3 case reports
Reactions Weekly, 2023, 1945 (1) : 497 - 497
[9] Cyclophosphamide/etoposide/tocilizumabLack of efficacy and neutropenia: 2 case reports
Reactions Weekly, 2020, 1807 (1) : 65 - 65
[10] Adalimumab/InfliximabLack of efficacy: 4 case reports
Reactions Weekly, 2024, 2027 (1) : 21 - 21

← 1 2 3 4 5 →